Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-005-9 | CAS number: 30030-25-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
- Endpoint:
- carcinogenicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 976
- Report date:
- 1976
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- The study was conducted before the time of adoption of OECD Test Guidelines on carcinogenicity and combined chronic toxicity/carcinogenicity.
6-month exposure period of 144-159 mice per dose level, with consecutive observation of most of the animals for their whole lifespan (maximum 25 months), and pathological as well as histopathological examination of lungs and liver after necropsy - GLP compliance:
- not specified
Test material
- Reference substance name:
- (chloromethyl)vinylbenzene
- EC Number:
- 250-005-9
- EC Name:
- (chloromethyl)vinylbenzene
- Cas Number:
- 30030-25-2
- Molecular formula:
- C9H9Cl
- IUPAC Name:
- 1-(chloromethyl)-3-ethenylbenzene; 1-(chloromethyl)-4-ethenylbenzene
- Test material form:
- liquid
- Details on test material:
- The test sample of vinylbenzyl chloride was 98.49% pure with 0.14% of vinyl toluene, 0.20% of alpha chlorinated vinyl toluene, 0.47% of beta chlorinated vinyl toluene, 0.23% of dichloroethyl toluene and 0.24% of unknown a impurities.
The sample contained 67.91% meta- and 30.58% para-isomers of vinylbenzyl chloride.
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- Swiss Webster
- Sex:
- not specified
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- air
- Details on exposure:
- Exposures were conducted in 3.7 m3 stainless steel chambers under dynamic airflow conditions. The exposure atmosphere in each chamber was generated by metering liquid vinylbenzyl chloride into a heated glass vaporizer at a calculated rate. The vapors emerging from the vaporizer were diluted with room air at a rate to provide the desired test material concentration. The nominal concentration in the chamber atmosphere was the ratio of the rate of vinylbenzyl chloride delivery to the rate of total chamber airflow (the volume of air ejected from the vaporizer plus the volume of make-up air).
- Analytical verification of doses or concentrations:
- yes
- Remarks:
- by gas chromatography, two times on 124 or 125 days
- Details on analytical verification of doses or concentrations:
- 20 L of air from the exposure chamber were drawn at the rate of 1 L/min through 25 mL of cold methanol in a fritted bottom bubbler. The vinylbenzyl chloride (VBC) dissolved in methanol was extracted with 10 mL of carbon disulfide. The quantity of VBC in a 2 µL sample of VBC-CS2 solution was analyzed by means of a gas chromatographic technique. The concentration of VBC in each sample was found by interpolation from a curve prepared with standard VBC solutions in CS2.
There were some day-to-day variations in chamber VBC concentration. However, 80-90% of the total exposure days were within +50% of the designated levels. There was no overlapping of concentration between the high and low range throughout the exposure period. - Duration of treatment / exposure:
- 6 hours per day
- Frequency of treatment:
- 5 days per week (months 1-6 of study)
- Post exposure period:
- months 7-25 of study
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.1 ppm (nominal)
- Dose / conc.:
- 1 ppm (nominal)
- No. of animals per sex per dose:
- 144-159
- Control animals:
- yes, concurrent vehicle
- yes, historical
- Details on study design:
- In total, animals were exposed on 131 days in 6 months. Food and water were removed from all animals during the exposure period. Even though controls were not placed in chambers, food and water were removed from them during the exposure period. After the 6 month exposure period, the mice were kept under ambient conditions and observed for the duration of their lifespan (maximum of 25 months).
Examinations
- Observations and examinations performed and frequency:
- Animals were observed throughout the study for changes and demeanor. Body weights were recorded once a week for 3 months of the study and monthly thereafter.
- Sacrifice and pathology:
- All mice were held for observation until they died or were killed in a moribund condition. Each mouse was subjected to a thorough necropsy examination, with specific emphasis on the presence or absence of tumorous lesions. All major organs and tissues were preserved in 10% formalin. Microscopic examination was conducted on all lungs and livers in which gross necropsy examination had revealed the presence of nodular lesions suggestive of a proliferative pathologic process, such as tumor formation.
- Statistics:
- Statistical analysis of body weights were carried out using an analysis of variance and Dunnett's Test. The mortality data and tumor incidence were analyzed with Fisher's Exact Probability Test. The level of significance in all statistical analysis was p <0.05.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- During the exposures, the mice exposed to 1 ppm vinylbenzyl chloride (VBC) exhibited slight transient eye and nasal irritation. The signs of irritation disappeared soon after termination of exposure to VBC each day.
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- Examination of the mortality data for mice reveals that deaths began to occur soon after initiation of exposure. Deaths of exposed mice began to accelerate by the fifth exposure week and continued until the second or third month of the post-exposure period. For the control mice, there were no deaths until the third month of the exposure period, at which time a similar mortality pattern began to occur. Necropsy examination revealed an ascending urinary tract infection in a majority of these mice. This presented as a necrotic purulent balanoposthitis, purulent urethritis, urinary retention in the urinary bladder and urocystitis. Microbiological cultures from these cases revealed the presence of various bacterial organisms, including species of Salmonella, Proteus, Pseudomonas, E. coli and Staphylococcus. Some of the mice had traumatic lesions indicative of cannibalism.
- Body weight and weight changes:
- no effects observed
- Food efficiency:
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Lungs and livers of the mice were examined for tumors. Pulmonary adenomas and carcinomas as well as benign hepatic tumors, hepatocellular carcinomas and angiosarcomas in liver were distinguished by gross pathological and histopathological inspection (see histopathological findings, non-neoplastic).
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Lungs and livers of the mice were examined for tumors. Pulmonary adenomas and carcinomas as well as benign hepatic tumors, hepatocellular carcinomas and angiosarcomas in liver were distinguished by gross pathological and histopathological inspection.
Pulmonary adenomas and adenocarcinomas, both of probable alveolar origin, were noted in both control and two exposed groups of mice, with a lower incidence in the exposed groups of mice. The pulmonary tumors observed in the mice of this study were of the type commonly observed as spontaneous occurrences in mice of this strain. The temporal occurrence of the pulmonary tumors within intervals of six months did not appear to be influenced by exposure to vapors of vinylbenzyl chloride (VBC).
Some mice from control and exposed groups showed gross and microscopic evidence of liver tumors. The incidence was highest in the control group. Tumors of hepatocellular origin included one morphologically benign hepatic tumor in a mouse of the 1.0 ppm VBC group and 4 morphologically malignant hepatocellular carcinomas, of which 3 out of 4 occurred i n the control group and one out of 4 occurred in the low exposure (0.1 ppm) group. In the liver of one control mouse a tumorous mass was found which was considered to be a hemangioma. No tumors of this latter type were noted in the groups of mice exposed to vapors of VBC. - Other effects:
- not specified
- Relevance of carcinogenic effects / potential:
- The occurance of benign and malign lung and liver tumors, which in total were more frequently found in the control group, was distinguished by gross pathological and histopathological examination. The incidence of these tumors did not appear to be influenced by exposure to vapors of vinylbenzyl chloride (VBC).
Effect levels
- Key result
- Dose descriptor:
- NOAEC
- Effect level:
- ca. 1 ppm (nominal)
- Basis for effect level:
- gross pathology
- histopathology: neoplastic
Applicant's summary and conclusion
- Conclusions:
- The results of this study are interpreted to indicate that lifetime observation of mice inhaling 0.1 or 1.0 ppm VBC for 6 hours/day, 5 days per week for 6 months had no discernible ill effects, including carcinogenesis in lungs and liver, except for clinically observed reversible eye and nasal irritation in animals exposed to the 1.0 ppm level of VBC.
- Executive summary:
Groups of 144 -159 Swiss Webster mice were exposed to atmospheres containing 0, 0.1 and 1.0 ppm of vinylbenzyl chloride (VBC) 6 hours/day, 5 days/week for 6 months and subsequently observed for their natural lifespan (at maximum for 25 months). There was clinical evidence of slight reversible eye and nasal irritation during exposure to 1 ppm VBC but not during inhalation of 0.1 ppm VBC. Body weight of control and treatment groups showed no significant differences. An increased mortality observed from the fifth week in exposure groups and from the ninth week in control animals was considered to be not treatment-related as necropsy examination revealed an ascending urinary tract infection in a majority of these mice. The occurance of benign and malign lung and liver tumors, which in total were more frequently found in the control group, was distinguished by gross pathological and histopathological examination. The incidence of these tumors did not appear to be influenced by exposure to vapors of vinylbenzyl chloride (VBC).
The results of this study are interpreted to indicate that lifetime observation of mice inhaling 0.1 or 1.0 ppm VBC for 6 hours/day, 5 days per week for 6 months had no discernible ill effects, including carcinogenesis in lungs and liver, except for clinically observed reversible eye and nasal irritation in animals exposed to the 1.0 ppm level of VBC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.